Sanctuary of Endovascular Therapies 2020

Who Should Attend:
• Physicians involved in DLE management (general, vascular and plastic surgeons, podiatrists, diabetologists, ID specialists, neurologists, wound care specialists)
• Scientists and engineers involved in fundamental or translational biomaterial research
• R&D personnel from small and large pharmaceutical and biotechnology companies involved in the development of new therapeutic approaches for DLE
• Vascular Surgeons, Interventional Radiologists and Allied Health Professionals Who Treat Endovascular Disease.

Accreditation:
Physicians
Amedco LLC designates this live activity for a maximum of 9.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ASRT Credits:
• This activity is approved by ASRT (American Society of Radiologic Technologists) for a maximum of 17.0 Category A+ Credits.

• Attendees must attend each session in its entirety in order to receive credit for that session.
NOTE: CCI will accept these 15.0 Category A Credits as RCIS credits

What is this meeting about?
• Staying strong in the business of healthcare by translating techniques into the community practice innovation
• Peripheral Arterial Disease
• Superficial Venous Session Deep Veins
• Thoracic Arotic Session Abdominal Aortic
• Arch Thoracic Cardiac Valvular Disease
• Fellows Competition

Educational Objectives:
• Discuss diagnostic and treatment for carotid artery, doctorsaortic aneurysms, thoracic artery grafts and peripheral arterial/venous diseases.
• Describe the nuances of vascular anatomy as they relate to case selection.
• Compare current and future medical, surgical and endovascular treatment options for infrainguinal interventions.
• Review identification and management strategies for complications following endovascular revascularization.
• Analyze areas in need of clinical and translational research to advance the care of complex patients with vascular disease.